Clinical & Pharma

Can TAF1 Unlock New Cancer Therapies Without Harming Blood Cells?
Clinical & Pharma Can TAF1 Unlock New Cancer Therapies Without Harming Blood Cells?

In the quest for effective cancer therapies, scientists at the Sylvester Comprehensive Cancer Center at the University of Miami have embarked on groundbreaking research on the molecule TAF1. This DNA regulatory entity plays a pivotal role in hematopoiesis—the complex process of blood cell formation

Why Are ADHD Prescriptions Soaring in England?
Clinical & Pharma Why Are ADHD Prescriptions Soaring in England?

In England, the landscape of ADHD diagnoses and prescriptions has markedly shifted, reflecting growing awareness and changing societal attitudes toward the condition. Over the decade, ADHD diagnoses have surged as individuals and healthcare systems increasingly recognize the symptoms of this

How Did S. Agona Trigger a 2022 Foodborne Outbreak in China?
Clinical & Pharma How Did S. Agona Trigger a 2022 Foodborne Outbreak in China?

In July 2022, a significant foodborne outbreak occurred in Taiyuan, Shanxi Province, China, posing serious public health challenges and prompting swift investigative efforts. The outbreak was linked to the bacterium Salmonella Agona (S. Agona), known for its potential to cause gastrointestinal

West Pharma Soars Amid GLP-1 Drug Demand; Mixed Market Results
Clinical & Pharma West Pharma Soars Amid GLP-1 Drug Demand; Mixed Market Results

West Pharmaceutical Services has experienced significant financial success, with a notable 23.15% increase in its stock price, reaching $279.26. This surge is primarily driven by a higher-than-expected earnings report, surpassing Wall Street projections and signaling robust demand for its products.

Navigating PFAS Health Risks: Maine Doctor's Proactive Approach
Clinical & Pharma Navigating PFAS Health Risks: Maine Doctor's Proactive Approach

The widespread presence of perfluoroalkyl and polyfluoroalkyl substances, known as PFAS, has emerged as a modern environmental and health challenge. Recognized for their persistence in the environment, these "forever chemicals" have steadily infiltrated various aspects of daily life, becoming a

Will Africa's Pharma Market Hit $118 Billion by 2032?
Clinical & Pharma Will Africa's Pharma Market Hit $118 Billion by 2032?

Africa's pharmaceutical market is on the cusp of a transformative era, projected to expand from USD 64.2 billion in 2025 to USD 118.3 billion by 2032, at an impressive CAGR of 9.10%. The surge in this sector is largely attributed to an increase in chronic disease cases, improvements in regulatory

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later